Jeil Pharmaceutical Co.,Ltd
271980.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
528
Cost of Revenue
395
Gross Profit
133
Gross Margin
25.2%
Operating Income
-14
Operating Margin
-2.7%
Net Income
-22
Net Margin
-4.3%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
-8
EBITDA Margin
-1.5%
2023
12/31/2023
Revenue
545
Cost of Revenue
407
Gross Profit
138
Gross Margin
25.4%
Operating Income
7
Operating Margin
1.2%
Net Income
4
Net Margin
0.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
13
EBITDA Margin
2.4%
2022
12/31/2022
Revenue
542
Cost of Revenue
424
Gross Profit
118
Gross Margin
21.7%
Operating Income
-10
Operating Margin
-1.9%
Net Income
-10
Net Margin
-1.8%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-1
EBITDA Margin
-0.2%
2021
12/31/2021
Revenue
526
Cost of Revenue
409
Gross Profit
117
Gross Margin
22.3%
Operating Income
-8
Operating Margin
-1.5%
Net Income
-9
Net Margin
-1.8%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-2
EBITDA Margin
-0.3%
2020
12/31/2020
Revenue
518
Cost of Revenue
401
Gross Profit
118
Gross Margin
22.7%
Operating Income
10
Operating Margin
1.9%
Net Income
5
Net Margin
1.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
17
EBITDA Margin
3.3%